Revenue Growth of 42% year over year to $69.8 million
Raises Guidance to Reflect FY 2022 Revenue Growth of 38%
REDWOOD CITY, Calif.–(BUSINESS WIRE)–C3.ai, Inc. (“C3 AI,” “C3,” or the “Company”) (NYSE: AI), the Enterprise AI software company, today announced financial results for its fiscal third quarter ended January 31, 2022.
“Our third quarter results displayed strength in all aspects of our business, including revenue growth of 42% year over year,” said CEO Thomas M. Siebel. “These results were driven by substantially increased sales momentum due to the successful refocusing of our sales organizations, expanded customer count, increased industry diversification for our AI products and the further recognition of our technology leadership in this industry. We believe C3 AI is on track to establish a global leading market position in Enterprise AI.”
Mr. Siebel added, “We remain confident in our long-term prospects based on our accelerating progress and the magnitude of the addressable enterprise AI market opportunity. Given these trends and our progress to date, we have raised our fiscal year 2022 guidance to reflect revenue growth of 38% over fiscal year 2021.”
Fiscal Third Quarter 2022 Financial Highlights
Customer Wins and Expansions
Other Corporate Highlights
Financial Outlook:
The Company’s guidance includes GAAP and non-GAAP financial measures.
The following table summarizes C3 AI’s guidance for the full-year fiscal 2022:
(in millions) |
Full Year Fiscal 2022 Guidance |
|
Total revenue |
$251.0 – $252.0 |
|
Non-GAAP loss from operations |
($90.0) – ($94.0) |
A reconciliation of non-GAAP guidance measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty regarding, and the potential variability of, expenses that may be incurred in the future. Stock-based compensation expense-related charges, including employer payroll tax-related items on employee stock transactions, are impacted by the timing of employee stock transactions, the future fair market value of our common stock, and our future hiring and retention needs, all of which are difficult to predict and subject to constant change. We have provided a reconciliation of GAAP to non-GAAP financial measures in the financial statement tables for our historical non-GAAP results included in this press release. Our fiscal year ends April 30, and numbers are rounded for presentation purposes.
Conference Call Details
What: |
C3 AI Third Quarter Fiscal 2022 Financial Results Conference Call |
|
When: |
Wednesday, March 2, 2022 |
|
Time: |
2:00 p.m. PT / 5:00 p.m. ET |
|
Live Call: |
(833) 927-1758, Domestic |
|
|
(929) 526-1599, International |
|
|
Conference ID: 473103 |
|
Webcast: |
https://event.on24.com/wcc/r/3574335/DDB99DECA3706870460ABE808A34A0C9 (live and replay) |
Investor Presentation Details
An investor presentation providing additional information and analysis can be found at our investor relations page at ir.c3.ai.
Statement Regarding Use of Non-GAAP Financial Measures
The Company reports the following non-GAAP financial measures, which have not been prepared in accordance with generally accepted accounting principles in the United States (GAAP), in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.
We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP financial measures.
Other Metrics
Customer-Entity and Customer.
We define a Customer-Entity as each entity that is the ultimate parent of a party contracting with us.
We commonly enter into enterprise-wide agreements with Customer-Entities that include multiple operating units or divisions. We count as a Customer each distinct division, department, business unit, or group within a Customer-Entity that uses our product(s). In situations where our Customer (or Customer-Entity) has developed software using our C3 AI Suite or developed derivative works of our C3 AI Applications and has sold that software or service to its end customer(s), we also include such end customers in our Customer count. In addition, where our software is sold to a third-party under a reseller arrangement, we include the end customer of such arrangement in our Customer count. We only count Customers and Customer-Entities for which there is revenue in the period through a Customer-Entity contract. We exclude free trials from both our Customer-Entity and Customer counts.
During the period ending January 31, 2022, we performed an analysis of our Customer-Entity usage. We found that despite the definition our previous Customer count did not capture all the distinct divisions, departments, business units, or groups that were using our software or services. We also identified that while our previous Customer count included situations where (i) our Customer (or Customer-Entity) had developed software using our C3 AI Suite or derivative works of our C3 AI Applications and had sold that software or service to its end customer(s), and (ii) our software or services were sold to a third-party under a reseller arrangement, our previously stated definition did not explicitly include those scenarios.
For clarity, we have provided our customer count historically using both the prior and current methodology. We intend to only present the revised calculation of Customer on a go-forward basis, as we believe it is a more accurate representation. Please see the tables included at the end of this release for these calculations in Other Metrics.
Use of Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release other than statements of historical facts, including our market leadership position, anticipated benefits from our partnerships and investments, financial outlook, our business strategies, plans, and objectives for future operations, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “will” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks and uncertainties. Some of these risks are described in greater detail in our filings with the Securities and Exchange Commission, including our Quarterly Reports on Form 10-Q for the fiscal quarters ended July 31, 2021 and October 31, 2021 and, when available, January 31, 2022, although new and unanticipated risks may arise. The future events and trends discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, achievements, or events and circumstances reflected in the forward-looking statements will occur. Except to the extent required by law, we do not undertake to update any of these forward-looking statements after the date of this press release to conform these statements to actual results or revised expectations.
About C3.ai, Inc.
C3.ai, Inc. (NYSE:AI) is the Enterprise AI application software company. C3 AI delivers a family of fully integrated products including the C3 AI Suite, an end-to-end platform for developing, deploying, and operating enterprise AI applications and C3 AI Applications, a portfolio of industry-specific SaaS enterprise AI applications that enable the digital transformation of organizations globally.
C3.AI, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited) |
||||||||||||||||
|
|
Three Months Ended January 31, |
|
Nine Months Ended January 31, |
||||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Revenue |
|
|
|
|
|
|
|
|||||||||
Subscription(1) |
$ |
57,084 |
|
|
$ |
42,699 |
|
|
$ |
150,614 |
|
|
$ |
114,248 |
|
|
Professional services(2) |
|
12,689 |
|
|
|
6,410 |
|
|
|
29,828 |
|
|
|
16,685 |
|
|
Total revenue |
|
69,773 |
|
|
|
49,109 |
|
|
|
180,442 |
|
|
|
130,933 |
|
|
Cost of revenue |
|
|
|
|
|
|
|
|||||||||
Subscription(3) |
|
12,275 |
|
|
|
7,023 |
|
|
|
32,880 |
|
|
|
22,694 |
|
|
Professional services |
|
5,079 |
|
|
|
5,203 |
|
|
|
13,470 |
|
|
|
10,113 |
|
|
Total cost of revenue |
|
17,354 |
|
|
|
12,226 |
|
|
|
46,350 |
|
|
|
32,807 |
|
|
Gross profit |
|
52,419 |
|
|
|
36,883 |
|
|
|
134,092 |
|
|
|
98,126 |
|
|
Operating expenses |
|
|
|
|
|
|
|
|||||||||
Sales and marketing(4) |
|
43,146 |
|
|
|
28,450 |
|
|
|
126,134 |
|
|
|
64,898 |
|
|
Research and development |
|
40,931 |
|
|
|
18,748 |
|
|
|
104,166 |
|
|
|
48,145 |
|
|
General and administrative |
|
15,748 |
|
|
|
8,184 |
|
|
|
43,391 |
|
|
|
21,433 |
|
|
Total operating expenses |
|
99,825 |
|
|
|
55,382 |
|
|
|
273,691 |
|
|
|
134,476 |
|
|
Loss from operations |
|
(47,406 |
) |
|
|
(18,499 |
) |
|
|
(139,599 |
) |
|
|
(36,350 |
) |
|
Interest income |
|
410 |
|
|
|
129 |
|
|
|
1,077 |
|
|
|
997 |
|
|
Other income (expense), net |
|
7,742 |
|
|
|
1,721 |
|
|
|
5,471 |
|
|
|
4,163 |
|
|
Net loss before provision for income taxes |
|
(39,254 |
) |
|
|
(16,649 |
) |
|
|
(133,051 |
) |
|
|
(31,190 |
) |
|
Provision for income taxes |
|
193 |
|
|
|
203 |
|
|
|
594 |
|
|
|
456 |
|
|
Net loss |
$ |
(39,447 |
) |
|
$ |
(16,852 |
) |
|
$ |
(133,645 |
) |
|
$ |
(31,646 |
) |
|
Net loss per share attributable to Class A common shareholders, basic and diluted |
$ |
(0.38 |
) |
|
$ |
(0.23 |
) |
|
$ |
(1.29 |
) |
|
$ |
(0.64 |
) |
|
Net loss per share attributable to Class A-1 common shareholders, basic and diluted |
$ |
— |
|
|
$ |
(0.10 |
) |
|
$ |
— |
|
|
$ |
(0.52 |
) |
|
Net loss per share attributable to Class B common shareholders, basic and diluted |
$ |
(0.38 |
) |
|
$ |
(0.13 |
) |
|
$ |
(1.29 |
) |
|
$ |
(0.12 |
) |
|
Weighted-average shares used in computing net loss per share attributable to Class A common stockholders, basic and diluted |
|
101,593 |
|
|
|
68,648 |
|
|
|
100,341 |
|
|
|
43,481 |
|
|
Weighted-average shares used in computing net loss per share attributable to Class A-1 common stockholders, basic and diluted |
|
— |
|
|
|
6,667 |
|
|
|
— |
|
|
|
6,667 |
|
|
Weighted-average shares used in computing net loss per share attributable to Class B common stockholders, basic and diluted |
|
3,500 |
|
|
|
3,500 |
|
|
|
3,500 |
|
|
|
3,500 |
|
(1) |
Including related party revenue of $19,740 and $7,951 for the three months ended January 31, 2022 and 2021, respectively, and $39,960 and $21,571 for the nine months ended January 31, 2022 and 2021, respectively. |
|
(2) |
Including related party revenue of $4,892 and nil for the three months ended January 31, 2022 and 2021, respectively, and $12,890 and nil for the nine months ended January 31, 2022 and 2021, respectively. |
|
(3) |
Including related party cost of revenue of $191 and nil for the three months ended January 31, 2022 and 2021, respectively, and $388 and nil for the nine months ended January 31, 2022 and 2021, respectively. |
|
(4) |
Including related party sales and marketing expense of $2,398 and nil for the three months ended January 31, 2022 and 2021, respectively, and $2,590 and nil for the nine months ended January 31, 2022 and 2021, respectively. |
|
C3.AI, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except for share and per share data) (Unaudited) |
||||||||
|
|
January 31, 2022 |
|
April 30, 2021 |
||||
Assets |
|
|
|
|||||
Current assets |
|
|
|
|||||
Cash and cash equivalents |
$ |
204,531 |
|
|
$ |
115,355 |
|
|
Short-term investments |
|
764,104 |
|
|
|
978,020 |
|
|
Accounts receivable, net of allowance of $57 and $812 as of January 31, 2022 and April 30, 2021, respectively(1) |
|
68,178 |
|
|
|
65,460 |
|
|
Prepaid expenses and other current assets(2) |
|
25,754 |
|
|
|
14,302 |
|
|
Total current assets |
|
1,062,567 |
|
|
|
1,173,137 |
|
|
Property and equipment, net |
|
5,297 |
|
|
|
6,133 |
|
|
Goodwill |
|
625 |
|
|
|
625 |
|
|
Long-term investments |
|
54,012 |
|
|
|
— |
|
|
Other assets, non-current(3) |
|
65,006 |
|
|
|
16,582 |
|
|
Total assets |
$ |
1,187,507 |
|
|
$ |
1,196,477 |
|
|
Liabilities and stockholders’ equity |
|
|
|
|||||
Current liabilities |
|
|
|
|||||
Accounts payable(4) |
$ |
14,478 |
|
|
$ |
12,075 |
|
|
Accrued compensation and employee benefits |
|
22,588 |
|
|
|
21,829 |
|
|
Deferred revenue, current(5) |
|
58,524 |
|
|
|
72,263 |
|
|
Accrued and other current liabilities(6) |
|
33,598 |
|
|
|
18,318 |
|
|
Total current liabilities |
|
129,188 |
|
|
|
124,485 |
|
|
Deferred revenue, non-current |
|
924 |
|
|
|
2,964 |
|
|
Other long-term liabilities(7) |
|
30,720 |
|
|
|
7,853 |
|
|
Total liabilities |
|
160,832 |
|
|
|
135,302 |
|
|
Commitments and contingencies |
|
|
|
|||||
Stockholders’ equity |
|
|
|
|||||
Class A common stock, $0.001 par value. 1,000,000,000 shares authorized as of January 31, 2022 and April 30, 2021; 102,784,741 and 98,667,121 shares issued and outstanding as of January 31, 2022 and April 30, 2021, respectively |
|
103 |
|
|
|
99 |
|
|
Class B common stock, $0.001 par value; 3,500,000 shares authorized as of January 31, 2022 and April 30, 2021; 3,499,992 and 3,499,992 shares issued and outstanding as of January 31, 2022 and April 30, 2021, respectively |
|
3 |
|
|
|
3 |
|
|
Additional paid-in capital |
|
1,510,343 |
|
|
|
1,410,325 |
|
|
Accumulated other comprehensive (loss) income |
|
(796 |
) |
|
|
81 |
|
|
Accumulated deficit |
|
(482,978 |
) |
|
|
(349,333 |
) |
|
Total stockholders’ equity |
|
1,026,675 |
|
|
|
1,061,175 |
|
|
Total liabilities and stockholders’ equity |
$ |
1,187,507 |
|
|
$ |
1,196,477 |
|
(1) |
Including amounts from a related party of $15,727 and $15,180 as of January 31, 2022 and April 30, 2021, respectively. |
|
(2) |
Including amounts from a related party of $5,010 and $1,662 as of January 31, 2022 and April 30, 2021, respectively. |
|
(3) |
Including amounts from a related party of $17,356 and $6,602 as of January 31, 2022 and April 30, 2021, respectively. |
|
(4) |
Including amounts from a related party of $2,415 and $56 as of January 31, 2022 and April 30, 2021, respectively. |
|
(5) |
Including amounts from a related party of $575 and $7,697 as of January 31, 2022 and April 30, 2021, respectively. |
|
(6) |
Including amounts from a related party of $18,534 and $3,413 as of January 31, 2022 and April 30, 2021, respectively. |
|
(7) |
Including amounts from a related party of $2,448 and $4,895 as of January 31, 2022 and April 30, 2021, respectively. |
|
C3.AI, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) |
||||||||
|
|
Nine Months Ended January 31, |
||||||
|
|
|
2022 |
|
|
|
2021 |
|
Cash flows from operating activities: |
|
|
|
|||||
Net loss |
$ |
(133,645 |
) |
|
$ |
(31,646 |
) |
|
Adjustments to reconcile net loss to net cash used in operating activities |
|
|
|
|||||
Depreciation and amortization |
|
3,761 |
|
|
|
3,189 |
|
|
Non-cash operating lease cost |
|
2,369 |
|
|
|
2,474 |
|
|
Stock-based compensation expense |
|
77,813 |
|
|
|
14,270 |
|
|
Other |
|
255 |
|
|
|
(115 |
) |
|
Changes in operating assets and liabilities |
|
|
|
|||||
Accounts receivable(1) |
|
(1,963 |
) |
|
|
588 |
|
|
Prepaid expenses, other current assets and other assets(2) |
|
(21,108 |
) |
|
|
(6,931 |
) |
|
Accounts payable(3) |
|
2,237 |
|
|
|
7,447 |
|
|
Accrued compensation and employee benefits |
|
759 |
|
|
|
4,303 |
|
|
Operating lease liabilities |
|
(2,303 |
) |
|
|
(2,636 |
) |
|
Other liabilities(4) |
|
14,304 |
|
|
|
1,213 |
|
|
Deferred revenue(5) |
|
(15,779 |
) |
|
|
2,016 |
|
|
Net cash used in operating activities |
|
(73,300 |
) |
|
|
(5,828 |
) |
|
Cash flows from investing activities: |
|
|
|
|||||
Purchases of property and equipment |
|
(2,183 |
) |
|
|
(1,166 |
) |
|
Capitalized software development costs |
|
(500 |
) |
|
|
— |
|
|
Proceeds from sale of non-marketable equity security |
|
— |
|
|
|
725 |
|
|
Purchases of investments |
|
(540,290 |
) |
|
|
(232,287 |
) |
|
Maturities and sales of investments |
|
698,312 |
|
|
|
280,997 |
|
|
Net cash provided by investing activities |
|
155,339 |
|
|
|
48,269 |
|
|
Cash flows from financing activities: |
|
|
|
|||||
Proceeds from initial public offering and private placements, net of underwriting discounts |
|
— |
|
|
|
851,859 |
|
|
Proceeds from repayment of shareholder loan |
|
— |
|
|
|
26,003 |
|
|
Payment of deferred offering costs |
|
(105 |
) |
|
|
(6,710 |
) |
|
Proceeds from exercise of Class A common stock options |
|
19,334 |
|
|
|
13,825 |
|
|
Net cash provided by financing activities |
|
19,229 |
|
|
|
884,977 |
|
|
Net increase in cash, cash equivalents and restricted cash |
|
101,268 |
|
|
|
927,418 |
|
|
Cash, cash equivalents and restricted cash at beginning of period |
|
116,255 |
|
|
|
33,604 |
|
|
Cash, cash equivalents and restricted cash at end of period |
$ |
217,523 |
|
|
$ |
961,022 |
|
|
Cash and cash equivalents |
$ |
204,531 |
|
|
$ |
960,122 |
|
|
Restricted cash included in other assets |
|
12,992 |
|
|
|
900 |
|
|
Total cash, cash equivalents and restricted cash |
$ |
217,523 |
|
|
$ |
961,022 |
|
|
Supplemental disclosure of cash flow information—cash paid for income taxes |
$ |
677 |
|
|
$ |
435 |
|
|
Supplemental disclosures of non-cash investing and financing activities: |
|
|
|
|||||
Purchases of property and equipment included in accounts payable and accrued liabilities |
$ |
483 |
|
|
$ |
349 |
|
|
Right-of-use assets obtained in exchange for lease obligations |
$ |
26,529 |
|
|
$ |
— |
|
|
Unpaid liabilities related to intangible purchases |
$ |
2,500 |
|
|
$ |
— |
|
|
Receivable from exercise of stock options included in prepaid expenses, other current assets and other assets |
$ |
45 |
|
|
$ |
— |
|
|
Deferred offering costs included in accounts payable and accrued liabilities |
$ |
— |
|
|
$ |
503 |
|
|
Vesting of early exercised stock options |
$ |
2,391 |
|
|
$ |
2,073 |
|
Contacts
Investor Contact
ir@c3.ai
Press Contact
Lisa Kennedy
(415) 914-8336
pr@c3.ai
SINGAPORE, June 23, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare…
FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had…
Pemvidutide elicited significant weight loss and decreases in pro-inflammatory serum lipids associated with atherogenesis and…
TAIPEI, June 22, 2024 /PRNewswire/ -- The prestigious 2024 Tang Prize Laureates have been announced,…
Afrezza® Afrezza® (insulin human) Inhalation Powder. Study proves inhaled insulin is as effective as usual…
PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader…